"March 9, 2011 -- The FDA has approved Benlysta, the first new lupus treatment in 50 years.
An FDA advisory panel last November voted 13-2 in favor of approval. But the panel noted that Benlysta is no wonder drug. Overall, it offered a"...
Benlysta Patient Information including How Should I Take
In this Article
- What is belimumab (Benlysta)?
- What are the possible side effects of belimumab (Benlysta)?
- What is the most important information I should know about belimumab (Benlysta)?
- What should I discuss with my healthcare provider before receiving belimumab (Benlysta)?
- How is belimumab given (Benlysta)?
- What happens if I miss a dose (Benlysta)?
- What happens if I overdose (Benlysta)?
- What should I avoid while receiving belimumab (Benlysta)?
- What other drugs will affect belimumab (Benlysta)?
- Where can I get more information?
What should I discuss with my healthcare provider before receiving belimumab (Benlysta)?
You should not use belimumab if you are allergic to it.
To make sure you can safely receive belimumab, tell your doctor if you have any of these other conditions:
- an active or chronic infection;
- a history of cancer; or
- a history of depression or mental illness.
You may have thoughts about suicide while receiving belimumab, especially if you have a history of suicidal thoughts or actions.
FDA pregnancy category C. It is not known whether belimumab will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.
If you are pregnant, your name may be listed on a pregnancy registry. This is to track the outcome of the pregnancy and to evaluate any effects of belimumab on the baby.
It is not known whether belimumab passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are using belimumab.
How is belimumab given (Benlysta)?
Belimumab is injected into a vein through an IV. You will receive this injection in a clinic or hospital setting. Belimumab must be given slowly, and the IV infusion can take about an hour to complete.
The first 3 doses of belimumab are given 2 weeks apart. Then the injections are given every 4 weeks. Your dosing schedule may be different. Follow your doctor's instructions.
You may be given other medications to prevent certain side effects of belimumab.
Additional Benlysta Information
- Benlysta Drug Interactions Center: belimumab iv
- Benlysta Side Effects Center
- Benlysta Overview including Precautions
- Benlysta FDA Approved Prescribing Information including Dosage
Benlysta - User Reviews
Benlysta User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.